Flag of the European Union EU Clinical Trials Register Help

Clinical trials for DSM-IV

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    816 result(s) found for: DSM-IV. Displaying page 1 of 41.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2005-002090-76 Sponsor Protocol Number: CAF-MT Start Date*: 2007-06-14
    Sponsor Name:SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL DE HEBRON
    Full Title: Estudio de la eficacia de la cafeína en el tratamiento de mantenimiento de pacientes con dependencia de cocaína
    Medical condition: COCAINE DEPENDENCE
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001798-95 Sponsor Protocol Number: 170965 Start Date*: 2006-05-12
    Sponsor Name:Jari Tiihonen
    Full Title: Ketamiini hoitoresistentin depression hoidossa. Satunnaistettu, placebokontrolloitu rinnakkaisryhmätutkimus
    Medical condition: hoitoresistentti depressio
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-005011-25 Sponsor Protocol Number: 05-06/BF 2.649 Start Date*: 2006-03-01
    Sponsor Name:BIOPROJET
    Full Title: Open study of BF 2.649 in association with a mood stabilizer in depressed bipolar patients
    Medical condition: Patients with bipolar disorder (I or II) having a major depressive episode
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2006-002411-27 Sponsor Protocol Number: 2006-002411-27 Start Date*: 2006-10-24
    Sponsor Name:Universitair Psychiatrisch Centrum KU Leuven
    Full Title: Evaluation of the effect of escitalopram on cognitive and fine motor function in depressed elderly patients.
    Medical condition: Elderly depressed patients, MDD, DSM IV-TR, single episode or recurrent
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2009-010625-39 Sponsor Protocol Number: MZ09-PCP-SosPeter Start Date*: 2010-04-21
    Sponsor Name:Prague Psychiatric Center
    Full Title: QEEG cordance and EEG connectivity changes after administration of subanesthetic ketamine doses in depressive disorder patients
    Medical condition: INCLUSION CRITERIA: 1. Men and women at the age between 18 to 65 years, with dextromanual dominance. 2. Patients have to answer DSM IV criteria for the major depressive episode, without psychotic s...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-002133-13 Sponsor Protocol Number: PRA/BIA-2093-204 Start Date*: 2005-10-21
    Sponsor Name:BIAL - Portela & Ca, S.A.
    Full Title: EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2-093) IN ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER IN A DOUBLE-BLIND, FIXED MULTIPLE DOSE, RANDOMIZED, PLACEBO-CONTROLLED, MULTICE...
    Medical condition: Patients with acute manic episodes fulfilling DSM-IV criteria for Bipolar I Disorder.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2005-004186-41 Sponsor Protocol Number: EK 129/04 Start Date*: 2006-03-03
    Sponsor Name:University of Aachen
    Full Title: Cholinerg/dopaminerge Kontrolle von Aufmerksamkeitsprozessen bei schizophrenen Störungen
    Medical condition: Am Tag 1 erfolgt eine PET-Untersuchung. Am Tag 2 oder 3 bekommen die Probanden bzw. Patienten 5 mg Biperiden intravenös, 30 Minuten später erfolgt eine weitere PET-Untersuchung. Nach der PET-Unters...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-000088-12 Sponsor Protocol Number: D1443C00012 Start Date*: 2008-08-18
    Sponsor Name:Department of Psychiatry, LMU Munich
    Full Title: A prospective, single-blinded (rater-blinded), randomized, parallel group study of the efficacy of Quetiapine XR in the treatment of patients with Acute Stress Disorder (DSM-VI 308.3)
    Medical condition: 40 patients with Acute Stress Disorder will be recruited within 2 years. The subjects must meet DSM- IV criteria for acute stress disorder (no acute suicidality) and will be treated with Quetiapine...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2014-004393-41 Sponsor Protocol Number: 2004 Start Date*: 2015-05-13
    Sponsor Name:CUB Hospital Erasme
    Full Title: A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depre...
    Medical condition: The subjects enrolled in the study will be major patients with major depressive disorder diagnosed according to DSM-IV, receiving electroconvulsive therapy.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000223-42 Sponsor Protocol Number: ZiSe Start Date*: 2005-10-31
    Sponsor Name:University Hospital Hamburg-Eppendorf, Psychiatry
    Full Title: Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in patients with posttraumatic stress disorder (PTSD)
    Medical condition: Post-traumatic Stress Disorder (PTSD) according to DSM-IV criteria
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-001661-41 Sponsor Protocol Number: Ser01 Start Date*: 2006-06-08
    Sponsor Name:Karolinska University Hospital
    Full Title: Body Composition and Metabolic Changes During Antipsychotic Treatment. A Randomized Trial Comparing Sertindole and Olanzapine.
    Medical condition: Patients with schizophrenia diagnosis (DSM-IV)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-006940-69 Sponsor Protocol Number: 601 Start Date*: 2010-05-20
    Sponsor Name:Lund University Hospital
    Full Title: Add-on treatment of mental illness with anti-viral medicine
    Medical condition: Schizophrenia, bipolar disorder
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-004134-16 Sponsor Protocol Number: Start Date*: 2008-02-11
    Sponsor Name:Charité Universitätsmedizin Berlin
    Full Title: Effectiveness and Safety of Pregabalin (Lyrica) in treatment of in-patients with ethanol withdrawal syndrom
    Medical condition: Patients with alcohol dependence in withdrawal states.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-005708-17 Sponsor Protocol Number: ELB139202-05 Start Date*: 2006-03-27
    Sponsor Name:elbion AG
    Full Title: International, multicenter, randomized, double-blind, placebo controlled, two-period, cross-over study to demonstrate safety, tolerability and anxiolytic effects of 600 mg ELB139 given orally t.i.d...
    Medical condition: Male and female patients with diagnosis of concurrent panic disorder according to DSM-IV, with or without agoraphobia (DSM IV 300.21 and 300.1) according to Mini International Neuropsychiatric Inte...
    Disease: Version SOC Term Classification Code Term Level
    10037175
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-001471-37 Sponsor Protocol Number: B4Z-SB-LYDW Start Date*: 2006-10-31
    Sponsor Name:Lilly Deutschland GmbH, Teichweg 3, 35396 Gießen
    Full Title: A Randomized, Double-Blind Comparison of Atomoxetine versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
    Medical condition: Children and adolescents with ADHD (Attention-Deficit/Hyperactivity Disorder) and comorbid ODD (Oppositional Defiant Disorder).
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-007538-21 Sponsor Protocol Number: CYR-101C01 Start Date*: 2008-04-22
    Sponsor Name:CYRENAIC
    Full Title: A Multi-center, Inpatient and ambulatory, Phase 2, Double-blind, Randomised, Placebo-controlled Proof of Concept Study of CYR-101 in Patients with DSM-IV Schizophrenia
    Medical condition: Diagnosis of Schizophrenia in Male or female patients, as defined in Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revised (DSM-IV TR, APA 2000) and confirmed by the St...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039626 Schizophrenia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-013476-53 Sponsor Protocol Number: PHRC-N/2009/POK-01 Start Date*: 2010-09-02
    Sponsor Name:CHU de Nîmes
    Full Title: Evaluation des performances de l’imagerie cérébrale isotopique du métabolisme glucidique en TEP (18F-FDG) et de la perfusion en TEMP (99mTc-ECD) pour le diagnostic de maladie d’Alzheimer au stade p...
    Medical condition: Maladie d'alzheimer au stade prodromal
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-005122-45 Sponsor Protocol Number: D1441L00032 Start Date*: 2005-05-18
    Sponsor Name:AstraZeneca GmbH
    Full Title: RACE : Rapid Dose Escalation of Quetiapine versus Conventional Escalation in the Treatment of Patients with Acute Schizophrenia – a Multicentre, Double-blind, Parallel group, Randomized Study
    Medical condition: Patients hospitalised with a DSM-IV diagnosis of schizophrenia showing acute agitation and psychosis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-002055-15 Sponsor Protocol Number: J81J1100168007 Start Date*: 2014-01-28
    Sponsor Name:UNIVERSITY OF SASSARI
    Full Title: RANDOMIZED, CONTROLLED, MULTI-CENTER, INTERNATIONAL CLINICAL STUDY ON THE MOOD-STABILIZING EFFECTS OF MEMANTINE AS AN AUGMENTING AGENT vs. LAMOTRIGINE FOR ONGOING TREATMENT IN BIPOLAR-I DISORDER P...
    Medical condition: BIPOLAR I MOOD DISORDERS
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-004162-17 Sponsor Protocol Number: A0501061 Start Date*: 2015-03-24
    Sponsor Name:Pfizer Inc
    Full Title: A Multicenter, 10-Week, Randomized, Double-Blind Study Of Sertraline And Placebo In Children And Adolescents With Posttraumatic Stress Disorder (PTSD)
    Medical condition: Post-Traumatic Stress Disorder
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 15 08:02:48 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA